Financhill
Back

Lixte Biotechnology Holdings Vs. Moleculin Biotech Industry Stock Comparison

Sell
24

LIXT
Lixte Biotechnology Holdings

Last Price:
2.40
Seasonality Move:
26.57%
Sell
22

MBRX
Moleculin Biotech

Last Price:
5.06
Seasonality Move:
29.92%
Sell
24
Lixte Biotechnology Holdings (LIXT) is a Sell

Is Lixte Biotechnology Holdings a Buy, Sell or Hold?

  • The current Lixte Biotechnology Holdings [LIXT] share price is $2.29. The Score for LIXT is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • LIXT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
22
Moleculin Biotech (MBRX) is a Sell

Is Moleculin Biotech a Buy, Sell or Hold?

  • The current Moleculin Biotech [MBRX] share price is $4.92. The Score for MBRX is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • MBRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

LIXT Stock Price Chart

What is Lixte Biotechnology Holdings's stock price today?

  • The Lixte Biotechnology Holdings share price today is $2.29
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LIXT is experiencing selling pressure, which indicates risk of future bearish movement.

MBRX Stock Price Chart

What is Moleculin Biotech's stock price today?

  • The Moleculin Biotech share price today is $4.92
    The current trend is relatively stagnant and MBRX is experiencing selling pressure, which indicates risk of future bearish movement.

LIXT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.15 Sell
Relative Strength Index (14 RSI): 32.01 Sell
Chaikin Money Flow: -52576 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.71 - 3.37) Sell
Bollinger Bands (100): (2.08 - 3.08) Sell

MBRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.18 Sell
Relative Strength Index (14 RSI): 47.1 Sell
Chaikin Money Flow: -10376 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.44 - 4.98) Buy
Bollinger Bands (100): (4.99 - 9.91) Sell

LIXT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.67 Sell
20-day SMA: 2.95 Sell
50-day SMA: 2.91 Sell
200-day SMA: 2.54 Sell
8-day EMA: 2.64 Sell
20-day EMA: 2.85 Sell
50-day EMA: 2.86 Sell
200-day EMA: 3.22 Sell

MBRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.85 Buy
20-day SMA: 4.77 Buy
50-day SMA: 5.76 Sell
200-day SMA: 7.67 Sell
8-day EMA: 4.84 Buy
20-day EMA: 4.91 Buy
50-day EMA: 5.66 Sell
200-day EMA: 8.14 Sell

Lixte Biotechnology Holdings Earnings Growth & LIXT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Moleculin Biotech Earnings Growth & MBRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.79 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.05 per share, and a decrease next year of $0.00 per share.

Lixte Biotechnology Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Moleculin Biotech Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):